Humana Medicare Advantage Plans Targeting Hemlibra, Herceptin Hylecta With Step Therapy

 
• By Cathy Kelly

Fail first requirements for 2020 also target drugs for myelodysplastic syndrome and chronic obstructive pulmonary disease, building on the step therapy program launched by Humana in 2019.

Businessman are stepping up the stairs. Ideas stepped through obstacles. Mind your step concept.
Humana Adding New Drug Categories To Medicare Advantage Step Therapy Program

More from Market Access

More from Pink Sheet